Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Fluorescence-based nano-immunoassay IVD platform

Project description

Innovative in vitro diagnostics platform for immunoassays

In vitro diagnostics (IVDs) are tests performed on blood or tissue samples taken from the human body. IVD tests detect diseases or can be used to monitor a person's health condition to help cure, treat, or prevent diseases. In precision medicine, IVDs identify patients who are likely to benefit from specific treatments or therapies. Complicated reimbursement policy issues create financial barriers for the companies developing novel IVD immunoassays. The EU-funded NIMM project aims to create a platform for the development of accurate, sensitive, and low-cost immunoassays for antibody-related conditions using a novel fluorescent nanosensor-based technology.

Objective

Antibody-detection related to disease or to drug monitoring demands novel IVD tests that provide robust, rapid and early- stage diagnostics for improved and early on-set treatments. However, companies developing novel IVD immunoassays face an important barrier related to reimbursement policy issues when the IVD tests are introduced into national health systems. This barrier discourages many companies from pursuing the development of novel diagnostic tests because the investment necessary to introduce novel IVD tests in the market is hardly matched by the return of the investment. NIMM aims at providing a platform for the development of accurate, sensitive and inexpensive immunoassays for antibody-related conditions using a novel fluorescent nanosensor-based technology. The outcome of the project will pave the way to a commercial product to be sold in the Immunochemistry/Immunoassay segment of the IVD market, currently valued at 15 USD billion. Potential stakeholders in the outcome of NIMM include Public Health authorities and pharmaceutical companies.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

ERC-POC - Proof of Concept Grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2018-PoC

See all projects funded under this call

Host institution

ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNE
Net EU contribution
€ 149 952,00
Address
PASEO MIRAMON 182, PARQUE TECNOLOGICO DE SAN SEBASTIAN EDIFICIO EMPRESARIAL C
20009 San Sebastian
Spain
Region
Noreste País Vasco Gipuzkoa
Activity type
Research Organisations
Links
Total cost
€ 149 952,00

Beneficiaries (1)